GreyBird Ventures is named after the arctic tern, a bird that migrates 71,000 km annually. As they can live for 30 years, this is the lifetime equivalent of three trips to the moon and back. Not bad for a 100 gram bird. We strive to emulate its size to performance ratio as well as its global reach. GreyBird Ventures, LLC is the world’s first venture firm focused exclusively on solving the most critical diagnostic problems to accelerate the trend toward precision medicine. Launched by Tom Miller, Michael Devlin, and Scott Gazelle, and supported by a global network of Operating Advisors, we invest early and work closely with entrepreneurs who share our passion and belief that the precise diagnosis of disease is the necessary starting point for successful treatment. We are guided in all of our activities by a strong ethical filter to seek returns that are as humanitarian as they are financially rewarding.

2013
Venture Capital
Sector
Biotech
Mental Health
Next Generation Sequencing
Neuroscience
Personalized Treatment
Drug Therapy
Depression
AI Technology
Machine Learning
Deep Learning
Computer Vision
Offering Type
Business Model
Software

People

Jonathan Matus

Name

Title

Class

Ira Sobel

Name

Title

Class

Tali Gross

Name

Title

Class

Investment Portfolio

Active
2017
29

Startup

Status

Founded

Employees

Investment Round History

October 2021
Series A
$10,000,000

Startup

Date Announced

Round

Capital Raised

Co-Investors

News

Register Pro to view more

Pro

$50 per month

Sign up to keep browsing

You reached your pageview limit

  • Save profiles to your list
  • Basic search functionality
  • Browse our leading AI database

Select a Table to Export